Joel S Greenberger

9PUBLICATIONS
33CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCondensed matter imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 27, 2024
JP4-039, a Mitochondria-Targeted Nitroxide, Mitigates the Effect of Apoptosis and Inflammatory Cell Migration in the Irradiated Mouse Retina.

Jennifer O Adeghate, Michael W Epperly, Katherine Anne Davoli

|Feb 10, 2024
Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer.

Diala F Hamade, Michael W Epperly, Renee Fisher

|Sep 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.

Joanne B Weidhaas, Chen Hu, Ritsuko Komaki

|Jul 17, 2023
Inhibition of tyrosine kinase Fgr prevents radiation-induced pulmonary fibrosis (RIPF).

Amitava Mukherjee, Michael W Epperly, Renee Fisher

|Mar 29, 2023
Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation.

Diala F Hamade, Michael W Epperly, Renee Fisher

|May 28, 2022
Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22.

Alexis Espinal, Michael W Epperly, Amitava Mukherjee

Pageof 2

Frequent Collaborators

4 joint publications

Michael W Epperly

3 joint publications

Peter Wipf

3 joint publications

Amitava Mukherjee

1 joint publications

Julie Glowacki